Higher levels of insulin‐like growth factor‐1 in cord blood associate with risk of asthma at age 3
Pediatric Pulmonology · 2024
DOI: 10.1002/ppul.26780 ↗At a glance
Journal article in Pediatric Pulmonology, 2024. Written by Jose A Castro-Rodriguez and 3 co-authors. Institution: Department of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Católica De Chile, Santiago, Chile. Major MEDLINE topics: Insulin-Like Growth Factor I, Asthma. Cited 1 times so far (Crossref); 29 references. The full text is freely available in PubMed Central. Funded by: NHLBI NIH HHS, NIH HHS, National Institutes of Health.
Abstract (original language)
Rationale
Experimental studies and epidemiological data in adults suggest that somatomedin‐C (insulin‐like growth factor‐1, IGF‐1) may play a role in asthma by modulating airway inflammation, bronchial hyperreactivity, and airway smooth muscle hyperplasia. However, its role in children with asthma is not well understood.
Methods
We established a birth cohort with 339 Chilean pregnant mothers enrolled at the time of delivery from December 2014 to January 2016. We obtained cord blood at birth and followed the offspring every 6 months until 30 months of age, recording data on atopy, wheezing, and other respiratory illnesses. We measured IGF‐1 in cord blood and determined the Asthma Predictive Index (API) at 30 months. The cohort was divided according to the API.
Results
Complete data were available for 307/339 (91%) dyads, including 44 preschoolers with API+ and 263 with API–. Demographic characteristics were similar between groups, but mothers of API+ children had a higher prevalence of obesity, previous use of oral contraceptives, and higher education than those of API– children. API+ children had higher birth weight and significantly higher IGF‐1 in cord blood (37.4 ± 13.2 in API+ vs. 30.5 ± 13.0 ng/ml in API–, p = .01). In the multivariable analysis, IGF‐1 in cord blood remained independently associated with a higher risk of asthma (adjusted OR for API+ per ng/ml higher IGF‐1 = 1.03 [1.0–1.06], p = .015).
Conclusions
Higher insulin‐like growth factor‐1 in cord blood is associated with asthma risk in the preschool years.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Pediatric Pulmonology, School of Medicine, Pontificia Universidad Católica De Chile, Santiago, Chile.
- Department of Public Health, School of Medicine, Pontificia Universidad Católica De Chile, Santiago, Chile.
- Departments of Obstetrics and Neonatology, School of Medicine, Pontificia Universidad Católica De Chile, Santiago, Chile.
- Pulmonary, Allergy, and Sleep Medicine, Riley Children's Hospital and Indiana University, Indianapolis, Indiana, USA.
ORCID profiles: Jose A Castro-Rodriguez, Erick Forno
Funding
- NHLBI NIH HHS
- NIH HHS
- National Institutes of Health
Cite
APA
Castro-Rodriguez, J. A., Padilla, O., Casanello, P., & Forno, E. (2024). Higher levels of insulin‐like growth factor‐1 in cord blood associate with risk of asthma at age 3. Pediatric Pulmonology. https://doi.org/10.1002/ppul.26780
Vancouver
Castro-Rodriguez JA, Padilla O, Casanello P, Forno E. Higher levels of insulin‐like growth factor‐1 in cord blood associate with risk of asthma at age 3. Pediatric Pulmonology. 2024. doi:10.1002/ppul.26780
BibTeX
@article{CastroRodriguez2024,
author = {Castro-Rodriguez, Jose A and Padilla, Oslando and Casanello, Paola and Forno, Erick},
title = {Higher levels of insulin‐like growth factor‐1 in cord blood associate with risk of asthma at age 3},
journal = {Pediatric Pulmonology},
year = {2024},
doi = {10.1002/ppul.26780}
}
EUVIMED